Overview

Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus

Status:
Not yet recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
This multicenter, double-blinded, randomized controlled trial aims to evaluate the effect of berberine on preventing cardiovascular disease and diabetes mellitus among individuals with high cardiometabolic risk in China.
Phase:
Phase 4
Details
Lead Sponsor:
China National Center for Cardiovascular Diseases